Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses

Andrew L. Mellor, David H. Munn

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

The murine conceptus is protected from maternal immunity by cells expressing indoleamine dioxygenase (IDO), which catabolizes tryptophan. Induction of lethal maternal anti-fetal immunity requires effective pharmacologic inhibition of IDO enzyme activity and the presence of maternal T cells, but not B cells and also depends on the degree of maternal-fetal tissue incompatibility. Based on these findings, we propose a model to explain the role of IDO in suppressing maternal immunity and the mechanism of fetal allograft rejection, when IDO activity is inhibited during gestation. This model incorporates observations that fetal allograft rejection is T cell dependent, antibody-independent and is accompanied by a novel type of inflammation involving extensive complement deposition at the maternal-fetal interface, when IDO activity is blocked during murine pregnancy.

Original languageEnglish (US)
Pages (from-to)5-13
Number of pages9
JournalJournal of Reproductive Immunology
Volume52
Issue number1-2
DOIs
StatePublished - Oct 11 2001

Fingerprint

Dioxygenases
Tryptophan
Mothers
T-Lymphocytes
Immunity
Allografts
Pregnancy
Fetus
B-Lymphocytes
Inflammation
Antibodies
Enzymes

Keywords

  • Fetal allograft
  • Indoleamine 2,3-dioxygenase
  • Maternal immunity
  • Pregnancy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. / Mellor, Andrew L.; Munn, David H.

In: Journal of Reproductive Immunology, Vol. 52, No. 1-2, 11.10.2001, p. 5-13.

Research output: Contribution to journalArticle

@article{eb15389bef724e489a7e96366476d66f,
title = "Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses",
abstract = "The murine conceptus is protected from maternal immunity by cells expressing indoleamine dioxygenase (IDO), which catabolizes tryptophan. Induction of lethal maternal anti-fetal immunity requires effective pharmacologic inhibition of IDO enzyme activity and the presence of maternal T cells, but not B cells and also depends on the degree of maternal-fetal tissue incompatibility. Based on these findings, we propose a model to explain the role of IDO in suppressing maternal immunity and the mechanism of fetal allograft rejection, when IDO activity is inhibited during gestation. This model incorporates observations that fetal allograft rejection is T cell dependent, antibody-independent and is accompanied by a novel type of inflammation involving extensive complement deposition at the maternal-fetal interface, when IDO activity is blocked during murine pregnancy.",
keywords = "Fetal allograft, Indoleamine 2,3-dioxygenase, Maternal immunity, Pregnancy",
author = "Mellor, {Andrew L.} and Munn, {David H.}",
year = "2001",
month = "10",
day = "11",
doi = "10.1016/S0165-0378(01)00118-8",
language = "English (US)",
volume = "52",
pages = "5--13",
journal = "Journal of Reproductive Immunology",
issn = "0165-0378",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses

AU - Mellor, Andrew L.

AU - Munn, David H.

PY - 2001/10/11

Y1 - 2001/10/11

N2 - The murine conceptus is protected from maternal immunity by cells expressing indoleamine dioxygenase (IDO), which catabolizes tryptophan. Induction of lethal maternal anti-fetal immunity requires effective pharmacologic inhibition of IDO enzyme activity and the presence of maternal T cells, but not B cells and also depends on the degree of maternal-fetal tissue incompatibility. Based on these findings, we propose a model to explain the role of IDO in suppressing maternal immunity and the mechanism of fetal allograft rejection, when IDO activity is inhibited during gestation. This model incorporates observations that fetal allograft rejection is T cell dependent, antibody-independent and is accompanied by a novel type of inflammation involving extensive complement deposition at the maternal-fetal interface, when IDO activity is blocked during murine pregnancy.

AB - The murine conceptus is protected from maternal immunity by cells expressing indoleamine dioxygenase (IDO), which catabolizes tryptophan. Induction of lethal maternal anti-fetal immunity requires effective pharmacologic inhibition of IDO enzyme activity and the presence of maternal T cells, but not B cells and also depends on the degree of maternal-fetal tissue incompatibility. Based on these findings, we propose a model to explain the role of IDO in suppressing maternal immunity and the mechanism of fetal allograft rejection, when IDO activity is inhibited during gestation. This model incorporates observations that fetal allograft rejection is T cell dependent, antibody-independent and is accompanied by a novel type of inflammation involving extensive complement deposition at the maternal-fetal interface, when IDO activity is blocked during murine pregnancy.

KW - Fetal allograft

KW - Indoleamine 2,3-dioxygenase

KW - Maternal immunity

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=0034809511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034809511&partnerID=8YFLogxK

U2 - 10.1016/S0165-0378(01)00118-8

DO - 10.1016/S0165-0378(01)00118-8

M3 - Article

C2 - 11600174

AN - SCOPUS:0034809511

VL - 52

SP - 5

EP - 13

JO - Journal of Reproductive Immunology

JF - Journal of Reproductive Immunology

SN - 0165-0378

IS - 1-2

ER -